BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31195059)

  • 1. Heat-activated drug delivery increases tumor accumulation of synergistic chemotherapies.
    Dunne M; Epp-Ducharme B; Sofias AM; Regenold M; Dubins DN; Allen C
    J Control Release; 2019 Aug; 308():197-208. PubMed ID: 31195059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data demonstrating the
    Wang X; Regenold M; Dunne M; Bannigan P; Allen C
    Data Brief; 2023 Oct; 50():109545. PubMed ID: 37767124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.
    Desale SS; Raja SM; Kim JO; Mohapatra B; Soni KS; Luan H; Williams SH; Bielecki TA; Feng D; Storck M; Band V; Cohen SM; Band H; Bronich TK
    J Control Release; 2015 Jun; 208():59-66. PubMed ID: 25660204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
    Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
    J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo.
    Wang X; Yang R; Yuan C; An Y; Tang Q; Chen D
    Target Oncol; 2018 Aug; 13(4):481-494. PubMed ID: 29992403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining critical parameters that influence in vitro performance characteristics of a thermosensitive liposome formulation of vinorelbine.
    Regenold M; Steigenberger J; Siniscalchi E; Dunne M; Casettari L; Heerklotz H; Allen C
    J Control Release; 2020 Dec; 328():551-561. PubMed ID: 32896612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer.
    Dunne M; Dou YN; Drake DM; Spence T; Gontijo SML; Wells PG; Allen C
    J Control Release; 2018 Jul; 282():35-45. PubMed ID: 29673642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent.
    Liu J; Chi D; Pan S; Zhao L; Wang X; Wang D; Wang Y
    Int J Pharm; 2019 Feb; 557():264-272. PubMed ID: 30599233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes.
    Dicheva BM; ten Hagen TL; Schipper D; Seynhaeve AL; van Rhoon GC; Eggermont AM; Koning GA
    J Control Release; 2014 Dec; 195():37-48. PubMed ID: 25176578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy.
    Li Y; He D; Tu J; Wang R; Zu C; Chen Y; Yang W; Shi D; Webster TJ; Shen Y
    Nanoscale; 2018 May; 10(18):8628-8641. PubMed ID: 29697100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study.
    Besse HC; Bos C; Zandvliet MMJM; van der Wurff-Jacobs K; Moonen CTW; Deckers R
    PLoS One; 2018; 13(9):e0204063. PubMed ID: 30226898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
    Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
    Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topotecan and doxorubicin combination to treat recurrent ovarian cancer: the influence of drug exposure time and delivery systems to achieve optimum therapeutic activity.
    Patankar NA; Pritchard J; van Grinsven M; Osooly M; Bally MB
    Clin Cancer Res; 2013 Feb; 19(4):865-77. PubMed ID: 23303216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery.
    Borys N; Dewhirst MW
    Adv Drug Deliv Rev; 2021 Nov; 178():113985. PubMed ID: 34555486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggered release from thermosensitive liposomes improves tumor targeting of vinorelbine.
    Regenold M; Kaneko K; Wang X; Peng HB; Evans JC; Bannigan P; Allen C
    J Control Release; 2023 Feb; 354():19-33. PubMed ID: 36503069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.
    Gabizon AA
    Cancer Invest; 2001; 19(4):424-36. PubMed ID: 11405181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Long-Circulating and Fusogenic Liposomes Co-encapsulating Paclitaxel and Doxorubicin in Synergistic Ratio for the Treatment of Breast Cancer.
    Roque MC; Franco MS; Vilela JMC; Andrade MS; de Barros ALB; Leite EA; Oliveira MC
    Curr Drug Deliv; 2019; 16(9):829-838. PubMed ID: 31622204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.